Page last updated: 2024-12-06
4-hydroxyaminopropiophenone
4-Hydroxyaminopropiophenone (4-HAP) is a potent and selective inhibitor of monoamine oxidase A (MAO-A), an enzyme that breaks down neurotransmitters like serotonin, norepinephrine, and dopamine in the brain. It is synthesized through a multi-step process that involves the reaction of propiophenone with hydroxylamine. 4-HAP has been shown to exhibit antidepressant-like effects in animal models, potentially by increasing serotonin levels in the brain. However, its use as a therapeutic agent is limited due to its toxicity and potential for adverse effects. It is an important research tool for studying the role of MAO-A in various neurological and psychiatric disorders, including depression, anxiety, and Parkinson's disease.'
Cross-References
ID Source | ID |
PubMed CID | 65520 |
SCHEMBL ID | 12826176 |
MeSH ID | M0144732 |
Synonyms (13)
Synonym |
p-hydroxyaminopropiophenone |
para-hydroxylaminopropiophenone |
propiophenone, 4'-hydroxylamino- |
1-propanone, 1-(4-(hydroxyamino)phenyl)- |
4-hydroxyaminopropiophenone |
brn 2360943 |
55-34-5 |
p-hydroxylaminopropiophenone |
4-hydroxylaminopropiophenone |
propiophenone, 4'-(hydroxyamino)- |
SCHEMBL12826176 |
n-hydroxy-p-aminopropiophenon |
DTXSID20203531 |
Research Excerpts
Dosage Studied
Research
Studies (5)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 3 (60.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.60
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 12.60 (24.57) | Research Supply Index | 1.79 (2.92) | Research Growth Index | 4.39 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |